Effects on the marrow of chemotherapy, used for the treatment of lymphomas and leukaemias

J MADIGAN et al. Acta Unio Int Contra Cancrum. 1959.

. 1959:15(Suppl 1):194-5.

No abstract available

Similar articles

Effective use of a new alkylating agent in doses lethal to bone marrow with protection by tourniquets of marrow in the extremis.
GOODMAN LE, SCHILLING A, KRAMER SP, ULFOHN A, MILLER S, KRAVITZ S, GABY SD, BAKAL D, WITTEN B, SELIGMAN AM. GOODMAN LE, et al. Surg Forum. 1961;12:130-2. Surg Forum. 1961. PMID: 13900321 No abstract available.
Chemotherapy of the malignant lymphomas and leukemias.
GAMBLE JF. GAMBLE JF. Med Ann Dist Columbia. 1962 Apr;31:195-9. Med Ann Dist Columbia. 1962. PMID: 13896557 No abstract available.
[Treatment of cancers and malignant lymphomas with massive chemotherapy and marrow transplants].
MEZA C, LARRAIN C, OBERHAUSER E, ASALGADO N. MEZA C, et al. Rev Med Chil. 1962 Apr;90:328-35. Rev Med Chil. 1962. PMID: 14473235 Spanish. No abstract available.
Autologous bone marrow transplantation in haematologic malignancies.
Marmont AM, Carella AM. Marmont AM, et al. Haematologica. 1986 Jan-Feb;71(1):1-12. Haematologica. 1986. PMID: 3084348 Review. No abstract available.
Monoclonal antibody therapy of leukemia and lymphoma.
Jurcic JG, Caron PC, Scheinberg DA. Jurcic JG, et al. Adv Pharmacol. 1995;33:287-314. doi: 10.1016/s1054-3589(08)60672-9. Adv Pharmacol. 1995. PMID: 7495673 Review. No abstract available.